Brattea is a medical device research and development company.
Brattea is a medical device research and development company. Brattea focuses on the development and commercialization of renal denervation products with indications in hypertension, cancer pain and diabetes.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 22, 2022 | Series C | — | 1 |
Fosun International
|
— | Detail |
| Apr 6, 2021 | Series B | $20M | 1 |
Kuanping Capital
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Fosun International
|
Yes | Series C |
Kuanping Capital
|
Yes | Series B |